Acceptability of human papillomavirus immunization

Area of Science:

• Public Health
• Vaccinology
• Health Behavior

Background:

• Human papillomavirus (HPV) is a common sexually transmitted infection linked to various cancers.
• HPV vaccines aim to prevent HPV infection and related diseases, but vaccine uptake can be influenced by public perception.
• Understanding attitudes towards hypothetical HPV vaccines is crucial for developing effective public health strategies.

Purpose of the Study:

• To examine attitudes toward hypothetical human papillomavirus (HPV) vaccines among adolescent and adult women.
• To identify key factors influencing the acceptability of HPV vaccines in different demographic groups.
• To inform the development and implementation of HPV vaccination programs.

Main Methods:

• Individual interviews were conducted with 20 adolescent women (14-18 years) and 20 adult women (20-50 years) in clinical settings.
• Participants ranked nine hypothetical HPV vaccines based on varying attributes: cost, efficacy, targeted disease, and physician recommendation.
• Spearman rank correlation was used to assess concordance between adolescent and adult rankings.

Main Results:

• Adolescent and adult women showed high concordance in their vaccine rankings (Spearman rho = 0.9).
• Vaccine efficacy, physician's recommendation, and cost were the most significant factors influencing acceptability.
• Decision-making processes were complex, with participants simultaneously considering multiple vaccine characteristics.

Conclusions:

• Specific features of hypothetical HPV vaccines, particularly efficacy, physician endorsement, and cost, significantly impact vaccine acceptability.
• These findings highlight the importance of addressing cost and emphasizing physician recommendation in promoting HPV vaccine uptake.
• Tailoring communication strategies based on these salient factors may improve vaccination rates and reduce the burden of HPV-related diseases.